BRIEF-Immune Therapeutics says NAFDAC approves Lodonal

* NAFDAC approved lodonal as over counter, non-toxic adjunct

therapy in treatment of HIV/Aids and immune system regulator

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom; +1...

Read more